GlassScriptPhysician profile
Ashley B Berkley
NPI 1437395290
$4,189.05
in general payments reported to CMS, 2019-2025
38 companies · $381 in 2025
The $381 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $538 · 2020: $183 · 2021: $253 · 2022: $634 · 2023: $1,055 · 2024: $1,145 · 2025: $381.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,580 · Education: $0.79.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,580.33 |
| Education | $0.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $690.55 | 2021-2025 | Qulipta, Linzess, Ubrelvy |
| Novo Nordisk INC | $358.56 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Glaxosmithkline, LLC. | $307.64 | 2019-2024 | Trelegy Ellipta |
| Lilly USA, LLC | $292.05 | 2019-2024 | Mounjaro, Jardiance, Zepbound |
| E.R. Squibb & Sons, L.L.C. | $255.79 | 2022-2025 | Eliquis |
| Abbott Laboratories | $251.21 | 2022-2025 | Freestyle Libre 3, Eterna, Proclaim |
| Pfizer INC. | $250.03 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $243.56 | 2019-2024 | Farxiga, Breztri, Airsupra |
| Amgen INC. | $240.43 | 2019-2025 | Prolia, Evenity, Otezla |
| Astellas Pharma US INC | $234.70 | 2020-2024 | Veozah |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $150.16 | 2019-2025 | Xifaxan, Trulance |
| Merck Sharp & Dohme LLC | $95.81 | 2022-2024 | Gardasil 9, Vaxneuvance, Vaxelis |
| Exact Sciences Corporation | $94.32 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $72.08 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $68.74 | 2019-2023 | Xarelto |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Berkley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.